Leidos' Healthcare Business Sees Limited Future Upside From Increasing Competition, BofA Securities Says

MT Newswires Live

06/17

Leidos' (LDOS) healthcare business sees limited future upside from increasing competition, BofA Securities said in a Wednesday note.

BofA said it sees near-term pressure on the healthcare business as the U.S. Defense Health Agency seeks to work directly with suppliers in the Defense Health Management System Modernization program's maintenance phase.

It also said the upcoming Medical Disability Examinations recompete could weigh on Leidos' future share and pricing power.

The investment banking firm said it continues to recognize the value of Leidos' defense portfolio, but added that it does not believe investors will give credit for full value of the opportunities until the results begin to materialize.

BofA downgraded Leidos to neutral from buy and adjusted its price target to $125 from $200.

Price: 110.13, Change: -3.45, Percent Change: -3.04

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2644742103"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2644742103\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2644742103?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-17 22:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2644742103","market":"sg","top_or_hot":-1,"title":"Leidos' Healthcare Business Sees Limited Future Upside From Increasing Competition, BofA Securities Says","media":"MT Newswires Live","content":"<html><body><p> Leidos' (LDOS) healthcare business sees limited future upside from increasing competition, BofA Securities said in a Wednesday note.</p><p>BofA said it sees near-term pressure on the healthcare business as the U.S. Defense Health Agency seeks to work directly with suppliers in the Defense Health Management System Modernization program's maintenance phase.</p><p>It also said the upcoming Medical Disability Examinations recompete could weigh on Leidos' future share and pricing power.</p><p>The investment banking firm said it continues to recognize the value of Leidos' defense portfolio, but added that it does not believe investors will give credit for full value of the opportunities until the results begin to materialize.</p><p>BofA downgraded Leidos to neutral from buy and adjusted its price target to $125 from $200.</p><p>Price: 110.13, Change: -3.45, Percent Change: -3.04</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Leidos' Healthcare Business Sees Limited Future Upside From Increasing Competition, BofA Securities Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLeidos' Healthcare Business Sees Limited Future Upside From Increasing Competition, BofA Securities Says\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-06-17 22:54</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Leidos' (LDOS) healthcare business sees limited future upside from increasing competition, BofA Securities said in a Wednesday note.</p><p>BofA said it sees near-term pressure on the healthcare business as the U.S. Defense Health Agency seeks to work directly with suppliers in the Defense Health Management System Modernization program's maintenance phase.</p><p>It also said the upcoming Medical Disability Examinations recompete could weigh on Leidos' future share and pricing power.</p><p>The investment banking firm said it continues to recognize the value of Leidos' defense portfolio, but added that it does not believe investors will give credit for full value of the opportunities until the results begin to materialize.</p><p>BofA downgraded Leidos to neutral from buy and adjusted its price target to $125 from $200.</p><p>Price: 110.13, Change: -3.45, Percent Change: -3.04</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LABU","symbol_name":"三倍做多標普生物-Direxion","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2644742103","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2644742103","pubTimestamp":1781708063,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Leidos'  healthcare business sees limited future upside from increasing competition, BofA Securities said in a Wednesday note.BofA said it sees near-term pressure on the healthcare business as the U.S. Defense Health Agency seeks to work directly with suppliers in the Defense Health Management System Modernization program's maintenance phase.It also said the upcoming Medical Disability Examinations recompete could weigh on Leidos' future share and pricing power.The investment banking firm said it continues to recognize the value of Leidos' defense portfolio, but added that it does not believe investors will give credit for full value of the opportunities until the results begin to materialize.BofA downgraded Leidos to neutral from buy and adjusted its price target to $125 from $200.Price: 110.13, Change: -3.45, Percent Change: -3.04","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LABU":"三倍做多标普生物-Direxion","HCSG":"Healthcare Svcs Group Inc","BK4581":"高盛持仓","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","LDOS":"Leidos Holdings Inc","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","XBI":"SPDR S&P Biotech ETF","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","BK4137":"综合支持服务","XLV":"健康照护类股ETF-SPDR","BK4585":"ETF&股票定投概念","BK4123":"调查和咨询服务","BK4588":"碎股"},"translate_title":"美国银行证券表示，Leidos的医疗保健业务未来因竞争加剧而上涨空间有限","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XLV":1.5,"LABU":0.6,"HCSG":1.5,"LDOS":1.5,"XBI":0.6},"content_text":"Leidos' (LDOS) healthcare business sees limited future upside from increasing competition, BofA Securities said in a Wednesday note.BofA said it sees near-term pressure on the healthcare business as the U.S. Defense Health Agency seeks to work directly with suppliers in the Defense Health Management System Modernization program's maintenance phase.It also said the upcoming Medical Disability Examinations recompete could weigh on Leidos' future share and pricing power.The investment banking firm said it continues to recognize the value of Leidos' defense portfolio, but added that it does not believe investors will give credit for full value of the opportunities until the results begin to materialize.BofA downgraded Leidos to neutral from buy and adjusted its price target to $125 from $200.Price: 110.13, Change: -3.45, Percent Change: -3.04","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}